Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

V. S. Renukuntla; N. Ramchandani; J. Trast; M. Cantwell; R. A. Heptulla

doi:10.1089/dia.2016.2504

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

V. S. Renukuntla
, N. Ramchandani
, J. Trast
, M. Cantwell
, R. A. Heptulla

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	S39-S40
Journal	Diabetes Technology and Therapeutics
Volume	18
DOIs	https://doi.org/10.1089/dia.2016.2504
State	Published - Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

Access to Document

10.1089/dia.2016.2504

Cite this

@article{5a57e2d299db4c4c9c1feae28f2ef539,

title = "Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm",

author = "Renukuntla, \{V. S.\} and N. Ramchandani and J. Trast and M. Cantwell and Heptulla, \{R. A.\}",

year = "2016",

month = feb,

doi = "10.1089/dia.2016.2504",

language = "English (US)",

volume = "18",

pages = "S39--S40",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

AU - Renukuntla, V. S.

AU - Ramchandani, N.

AU - Trast, J.

AU - Cantwell, M.

AU - Heptulla, R. A.

PY - 2016/2

Y1 - 2016/2

UR - https://www.scopus.com/pages/publications/84957627215

UR - https://www.scopus.com/pages/publications/84957627215#tab=citedBy

U2 - 10.1089/dia.2016.2504

DO - 10.1089/dia.2016.2504

M3 - Comment/debate

AN - SCOPUS:84957627215

SN - 1520-9156

VL - 18

SP - S39-S40

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this